Old Web
English
Sign In
Acemap
>
authorDetail
>
Boris A. Hadaschik
Boris A. Hadaschik
Vancouver Prostate Centre
Medicine
Oncology
Prostate cancer
Positron emission tomography
intermediate risk
2
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Safety and efficacy of perioperative cisplatin/gemcitabine (cis/gem) and durvalumab (durva) for operable muscle-invasive urothelial carcinoma (MIUC): SAKK 06/17.
2021
Journal of Clinical Oncology
Richard Cathomas
Sacha I. Rothschild
Stefanie Hayoz
Martin Spahn
Julian Schardt
Roland Seiler
Andreas Erdmann
Stefanie Aeppli
Nicolas Mach
Raeto Strebel
Boris A. Hadaschik
Dominik Berthold
Miklos Pless
Deborah Zihler
Mathias Schmid
Martina Schneider
Zuzanna Maniecka
Ulf Petrausch
Show All
Source
Cite
Save
Citations (0)
Phase III randomized trial of PSMA PET prior to definitive radiation therapy for unfavorable intermediate-risk or high-risk prostate cancer [PSMA dRT]: Study protocol NCT04457245.
2021
Journal of Clinical Oncology
Jeremie Calais
Shaojun Zhu
Nader Hirmas
Matthias Eiber
Boris A. Hadaschik
Martin Stuschke
Ken Herrmann
Johannes Czernin
Amar U. Kishan
Nicholas G. Nickols
David Elashoff
Wolfgang P. Fendler
Show All
Source
Cite
Save
Citations (0)
1